S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The “Perfect Storm” for Gold (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The Next Nvidia? (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The “Perfect Storm” for Gold (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The Next Nvidia? (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The “Perfect Storm” for Gold (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The Next Nvidia? (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The “Perfect Storm” for Gold (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The Next Nvidia? (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
Free Trial
NYSE:GLS

Gelesis (GLS) Stock Price, News & Analysis

→ The Next Nvidia? (From InvestorPlace) (Ad)
Free GLS Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
N/A
50-Day Range
$0.11
▼
$0.33
52-Week Range
N/A
Volume
185,100 shs
Average Volume
386,034 shs
Market Capitalization
$11.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
GLS stock logo

About Gelesis Stock (NYSE:GLS)

Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipeline with potential therapies for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation. Gelesis Holdings Inc. was incorporated in 2006 and is headquartered in Boston, Massachusetts.

GLS Stock News Headlines

December 9, 2023 | morningstar.com
Gelesis Holdings Inc GLSHQ
April 11, 2023 | msn.com
NYSE to suspend trading immediately in Gelesis Holdings
April 18, 2024 | InvestorPlace (Ad)
The Next Nvidia?
The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.
April 10, 2023 | finance.yahoo.com
NYSE to Suspend Trading Immediately in Gelesis Holdings, Inc. (GLS) and Commence Delisting Proceedings
March 29, 2023 | msn.com
Looking Into Gelesis Holdings's Return On Capital Employed
March 28, 2023 | finance.yahoo.com
Gelesis Reports Fourth Quarter and Full Year 2022 Results
January 27, 2023 | seekingalpha.com
GLS Gelesis Holdings, Inc.
January 5, 2023 | finance.yahoo.com
Gelesis to Participate in the 25th Annual ICR Conference
April 18, 2024 | InvestorPlace (Ad)
The Next Nvidia?
The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.
January 4, 2023 | technews.tmcnet.com
NYSE to Suspend Trading Immediately in Warrants of Gelesis Holdings, Inc. (GLS WS) and Commence Delisting Proceedings
November 21, 2022 | finance.yahoo.com
Gelesis Reports Upcoming Participation in Wolfe Research’s Annual Consumer Growth Conference
November 18, 2022 | finance.yahoo.com
Gelesis Receives Notice of NYSE Market Capitalization Listing Rule Non-Compliance
November 14, 2022 | seekingalpha.com
Gelesis Holdings, Inc. (GLS) Q3 2022 Earnings Call Transcript
November 14, 2022 | finance.yahoo.com
Gelesis Reports Third Quarter 2022 Results
November 7, 2022 | finance.yahoo.com
Gelesis to Report Third Quarter 2022 Financial Results on November 14, 2022
November 4, 2022 | finance.yahoo.com
Gelesis Receives Notice of NYSE Trading Share Price Listing Rule Non-Compliance
November 2, 2022 | finance.yahoo.com
Data Presented at Obesity Week Demonstrate that Gelesis Investigational Clinical-Stage Oral Superabsorbent Hydrogel Gel-B Preferentially Enhances the Growth of Akkermansia muciniphila in Preclinical Models Compared to Prebiotics
November 1, 2022 | finance.yahoo.com
Dr. Frank Greenway to Present Data from the LIGHT-UP Study with Gelesis’ Oral Hydrogel Treatment GS200 at Obesity Week
October 5, 2022 | ca.finance.yahoo.com
Investors in Gelesis Holdings (NYSE:GLS) have unfortunately lost 89% over the last year
September 9, 2022 | morningstar.com
Gelesis Holdings Inc GLS Stock Analysis
September 8, 2022 | finance.yahoo.com
Gelesis to Participate in the Jefferies Virtual Fitness & Wellness Summit
August 25, 2022 | finance.yahoo.com
Clinical Data from the LIGHT-UP Study Presented at the International Congress of Endocrinology Suggests New Gelesis Oral Hydrogel May Improve Insulin Sensitivity and Favorably Impact Metabolic Syndrome
August 24, 2022 | nasdaq.com
Investors one-year losses grow to 89% as the stock sheds US$21m this past week
August 17, 2022 | finance.yahoo.com
REPLAY: Fight Obesity With Biotech – Gelesis CEO, CFO in Fireside Chat
August 17, 2022 | msn.com
Analyzing Gelesis Holdings Short Interest
August 17, 2022 | finance.yahoo.com
Gelesis to Participate in Fireside Chat with IPO Edge Today at 2:00 PM ET
August 16, 2022 | finance.yahoo.com
Arming Consumers to Fight Obesity with Biotech – Join CEO and CFO of Gelesis in Fireside Chat Wednesday at 2 ET
See More Headlines
Receive GLS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gelesis and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/18/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NYSE:GLS
CUSIP
N/A
CIK
1805087
Web
www.gelesis.com
Phone
N/A
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($1.40)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-56,030,000.00
Net Margins
-221.38%
Pretax Margin
-214.62%
Return on Equity
N/A
Return on Assets
-14.98%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.30
Quick Ratio
0.21

Sales & Book Value

Annual Sales
$25.77 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.34) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
73,333,000
Free Float
64,606,000
Market Cap
$11.63 million
Optionable
Not Optionable
Beta
0.88
Beginners Guide To Retirement Stocks Cover
Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Yishai Zohar (Age 59)
    Founder, Pres, CEO & Director
    Comp: $689.95k
  • Mr. Elliot Maltz CPA (Age 37)
    CFO & Treasurer
    Comp: $486.26k
  • Dr. David Pass Pharm.D. (Age 53)
    COO & Chief Commercial Officer
  • Dr. Elaine Chiquette Pharm.D. (Age 55)
    Chief Scientific Officer
  • Ms. Joy Bauer M.S.
    MS, RDN, Chief Nutrition Officer of Plenity

Key Competitors

View All Competitors

This page (NYSE:GLS) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
Biden replacement revealed?
Paradigm Press
The “Perfect Storm” for Gold
Gold Safe Exchange
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Your Money is Not Safe
American Alternative
The Next Nvidia?
InvestorPlace